Clinical trial · Observational
Medical Data Collection in the Formation of Precision Oncology Registry
Formation of a Precision Oncology Registry
NCT03874065CI-TRIAL-00073141terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PI left institution
Summary
Brief summary (as posted)
In efforts to develop an aggregation point for patient clinical data and data related to DNA sequencing in the Comprehensive Cancer Center, this registry will be developed to provide a comprehensive data store. The goal of the registry will be to collect information on the Cancer Center population undergoing next generation DNA sequencing (NGS) on their tumors or liquid biopsies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Medical Chart Review | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (7)
- measure
- Data Collection of Demographics, Disease and Previous Treatment
- timeFrame
- Approximately 2 years
- description
- To capture characteristics of the patient population undergoing next generation DNA sequencing of their tumor or liquid biopsy for more efficient clinical operations by collecting data on demographics, disease, and previous treatment.
- measure
- Modes of Treatment for Patients
- timeFrame
- Approximately 2 years
- description
- To gather information on the number and type of patients that receive off label, standard, timeline or other experimental treatments based on the NGS data.
- measure
- Populations Requiring Financial Assistance
- timeFrame
- Approximately 2 years
- description
- To gather data regarding the patient population that may require financial assistance
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: • All cancer patients at Wake Forest Baptist Comprehensive Cancer Center and its satellites who are having next generation DNA sequencing ordered/performed on their tumor biopsy or surgically resected tissue and/or blood samples. Exclusion Criteria: Not applicable
References
Publications (0)
Data not yet available
No reference posted for this study.